The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Sanfilippo Syndrome Market Across 2026–2030?
The sanfilippo syndrome market has experienced rapid expansion in recent years. It is forecast to grow from $9.21 billion in 2025 to $10.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.5%. This historical growth can be linked to factors such as limited treatment options for sanfilippo syndrome, a rise in the recognition of lysosomal storage disorders, the proliferation of rare disease advocacy groups, incremental improvements in diagnostic capabilities, and early-stage research funding for orphan diseases.
The Sanfilippo Syndrome market size is projected to witness significant expansion in the coming years, reaching $15.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.2%. This projected growth is largely attributable to advancements in AAV-based gene therapies, an increase in orphan drug designations and incentives, rising healthcare expenditure on rare diseases, expanding newborn screening initiatives, and growing investment from biotech and pharmaceutical companies. Major trends expected during this period include intensifying clinical trial activity for Sanfilippo Syndrome therapies, a growing adoption of gene therapy approaches in pediatric neurodegenerative disorders, an increased use of advanced diagnostic techniques for early detection, the expansion of compassionate use and early access programs for rare diseases, and enhanced collaboration between biotech firms and research institutions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23507&type=smp
Which Market Drivers Are Supporting The Expansion Of The Sanfilippo Syndrome Market?
A growing emphasis on gene therapies is anticipated to propel the expansion of the sanfilippo syndrome market moving forward. These medical treatments involve modifying or replacing faulty genes to address or prevent diseases. The heightened focus on gene therapies stems from their potential to treat genetic disorders, rare diseases, and chronic conditions by targeting their fundamental cause at a molecular level. For Sanfilippo syndrome, gene therapies assist in treatment by delivering functional copies of the defective gene to reinstate enzyme production, thereby reducing the accumulation of harmful substances within cells. For instance, in April 2024, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported that in Q4 2023, the count of phase III gene therapy clinical trials increased by 10%, marking the first quarterly rise since Q3 2022. Hence, the increasing focus on gene therapies is driving the growth of the sanfilippo syndrome market.
What Segmentation Levels Are Considered In The Sanfilippo Syndrome Market?
The sanfilippo syndrome market covered in this report is segmented –
1) By Treatment: Enzyme Replacement Therapy, Gene Therapy, Genistein, Other Treatments
2) By Diagnosis: Glycosaminoglycan Analysis (GAG Analysis), Genomic Deoxyribonucleic Acid Sequencing (Genomic DNA Sequencing), Activity Assay, Other Diagnosis
3) By End-User: Hospitals, Research Institutions
Subsegments:
1) By Enzyme Replacement Therapy: Intravenous Enzyme Replacement Therapy, Intrathecal Enzyme Replacement Therapy, Intracerebroventricular (ICV) Enzyme Replacement Therapy
2) By Gene Therapy: Adeno-Associated Virus (AAV)-Based In Vivo Gene Therapy, Lentiviral Vector–Based Ex Vivo Gene Therapy, Non-Viral Vector Gene Delivery
3) By Genistein: Oral Genistein Supplementation, High-Dose Genistein Regimens, Low-Dose Genistein Regimens
4) By Other Treatments: Substrate Reduction Therapy (SRT), Stem Cell Therapy, Anti-Inflammatory Agents, Symptomatic Management Drugs
What Key Trends Are Influencing The Development Of The Sanfilippo Syndrome Market?
Leading companies in the sanfilippo syndrome market are concentrating on developing innovative treatments, such as gene therapies, to enhance patient outcomes and slow disease progression. Gene therapy is a medical strategy that employs genes to prevent, treat, or cure diseases by correcting or replacing faulty genes within the body. For instance, in February 2025, Ultragenyx Pharmaceutical Inc., a US-based biopharmaceutical company, presented new findings on UX111 (ABO-102), an AAV gene therapy for sanfilippo syndrome Type A (MPS IIIA). This treatment showed statistically significant improvements in Bayley-III raw scores for cognition, receptive communication, and expressive communication. Moreover, it resulted in a substantial and sustained reduction in cerebrospinal fluid (CSF) heparan sulfate (HS) levels, which correlated with improved clinical outcomes.
Which Leading Firms Are Contributing To The Growth Of The Sanfilippo Syndrome Market?
Major companies operating in the sanfilippo syndrome market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceutical Inc, Ultragenyx Pharmaceutical Inc, JCR Pharmaceuticals Co Ltd, Denali Therapeutics Inc, REGENXBIO Inc, Greenwood Genetic Center, ArmaGen Inc, Abeona Therapeutics Inc, Orchard Therapeutics plc, Allievex Corporation, Lysogene SA, Sio Gene Therapies Inc, Abeona Therapeutics Europe, Spark Therapeutics Inc, PTC Therapeutics Inc, Neurogene Inc, Taysha Gene Therapies Inc, MeiraGTx Holdings plc, Sangamo Therapeutics Inc, Freeline Therapeutics Holdings plc, LogicBio Therapeutics Inc
Read the full sanfilippo syndrome market report here:
https://www.thebusinessresearchcompany.com/report/sanfilippo-syndrome-global-market-report
How Is The Sanfilippo Syndrome Market Distributed Across Key Geographic Regions?
North America was the largest region in the sanfilippo syndrome market in 2025. The regions covered in the sanfilippo syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sanfilippo Syndrome Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=23507&type=smp
Browse Through More Reports Similar to the Global Sanfilippo Syndrome Market 2026, By The Business Research Company
Antiphospholipid Syndrome Treatment Global Market Report
Polycystic Ovarian Syndrome Treatment Global Market Report
Dry Eye Syndrome Global Market Report
https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model